Conventus Orthopaedics, Inc., a Minneapolis-based medical device company focused on extremity fracture treatment, completed a $20m equity financing.
The round was led by Deerfield Management.
The company will use the funds to advance its tech device.
Led by Scott Flora, Executive Chairman, Conventus is advancing an intramedullary implant for the repair of extremity fractures, currently FDA cleared for the treatment of shoulder, elbow and wrist fractures. According to a written note, early clinical results have been promising as patients have experienced a stable fracture fixation with a quicker recovery period, less pain, improved range of motion, and fewer surgical complications when compared to historical literature for existing fracture repair methods.